ghk-cu/bpc-157/tb-500 dosage KLOW Dosing Guide: GHK-Cu + KPV + BPC-157 + TB-500 Protocol & Reconstitution (2026) ghk cu bpc 157 tb

While both have demonstrated potential in soft tissue and dermal repair models, specific evidence addressing lumbar disc degeneration remains limited, and neither compound possesses substantial clinical trial support in this application

The machinery it drives inside the cell maxes out long before the receptor itself fills, so the effect can run flat-out while occupancy is still tiny (the spare-receptor effect). Retatrutide runs on this

Unlike GLP-1 agonists, BPC-157 is not a hormone mimic

BPC157: healing and antiinflammatory properties BPC157 is a 15aminoacid fragment derived from a gastric protein

The theoretical cancer concern applies to TB-500 as well, though perhaps to a lesser extent